Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
1911 Gold Announces C$11.5 Million “Bought Deal” Life Offering and Private Placement
-
TOUCHMARK BANCSHARES, INC. ANNOUNCES DIRECTOR APPOINTMENTS
-
East Africa Metals Provides Update on Ethiopia Projects and Regional Developments
-
Chile Announces Exchange Offer for Euro-Denominated Notes
-
INVESTOR ALERT: Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - TEM
-
Administrative Law Judge Determines ReWalk Personal Exoskeleton is “Reasonable and Necessary” for Medicare Beneficiary
-
Ethereum (ETH) Whale Allocates $250K to Little Pepe (LILPEPE) Presale as Stage 3 Gains Momentum
-
June is Men's Health Month; Daily Skincare is part of Year-Round Health for Men
-
Corbus Pharmaceuticals to Participate in the 3rd Annual Piper Obesity Symposium
-
Highwoods to Release Second Quarter 2025 Results Tuesday, July 29th
-
BioVie to Present Overview of Phase 2 SUNRISE-PD Trial at the Advanced Therapeutics in Movement & Related Disorders® Congress
-
AeroVironment Announces Fiscal 2025 Fourth Quarter and Fiscal Year Results
-
LAZYDAYS AND RON HOOVER RV & MARINE ENTER INTO AGREEMENT FOR TULSA, OK STORE LOCATION
-
Comstock Metals and Virtus Renewables Form Strategic Solar Recycling Partnership
-
NetApp Appoints Disruptive Innovator Syam Nair as Chief Product Officer, Underscoring its Commitment to Bold Product Vision
-
Mastercard Board of Directors Announces Quarterly Dividend
-
Rafael Sanchez Joins Bloomin’ Brands as Chief Information Officer
-
-
InspireMD Announces FDA Approval for CGuard® Prime Carotid Stent System for the Prevention of Stroke
-
POSaBIT Announces Results of Annual and Special Meeting of Shareholders
-
EnviroGold Global Announces Executive Promotions to Support Commercial Deployment and Growth
-
NeuroPace Announces Strategic CFO Transition
-
Intelligent Protection Management Corp. Adds Aura's Comprehensive Personal Identity Theft Protection Products to its Cutting-Edge Enterprise IT Infrastructure and Cybersecurity Tools
-
Mirion Technologies and Westinghouse Partner to Drive Digital Innovation in Nuclear Instrumentation Systems
-
FedEx Reports Fourth Quarter Diluted EPS of $6.88 and Adjusted Diluted EPS of $6.07
-
Verastem Oncology Announces First Patient Dosed with VS-7375, an Oral KRAS G12D (ON/OFF) Inhibitor, in a U.S. Phase 1/2a Trial in KRAS G12D Advanced Solid Tumors
-
ROSEN, LEADING INVESTOR COUNSEL, Encourages DoubleVerify Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DV
-
VSTS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Vestis Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
PEPG INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that PepGen Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
BRMK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Broadmark Realty Capital Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
FTRE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Fortrea Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
OGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
DMRC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Digimarc Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
BITF INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Bitfarms Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
Credit Acceptance Announces Extension of Revolving Secured Line of Credit Facility
-
Syndax Announces FDA Priority Review of sNDA for Revuforj® (revumenib) in Relapsed or Refractory mNPM1 Acute Myeloid Leukemia
-
Forte Biosciences Announces Proposed Public Offering
-
Graphjet Technology Discloses Notice from Nasdaq
-
Arsenal Digital Holdings, Inc. (OTC:ADHI) Announces Appointment of New CEO, President, CMO, and Board Chairman
-
Accelerating Child Exploitation Investigations: Cellebrite Integrates Data from the National Center for Missing and Exploited Children (NCMEC)
-
Massachusetts Health Data Consortium and ZeOmega, Inc. Launch Statewide Network to Automate Prior Authorization and Clinical Data Exchange
-
TRIO Advances Design Research Through Strategic Academic Partnerships
-
PHINIA Inc. to Report Q2 2025 Earnings
-
Abvance Therapeutics Secures Strategic Seed Financing & Leadership Expansion at ADA Scientific Sessions
-
HashJ Cloud Mining Platform Launches ETH Cloud Mining Service, Opening New Digital Wealth Opportunities for Investors!
-
General Atomics Achieves Another Milestone in Silicon Carbide Composite Nuclear Fuel Rod Technology
-
Sadot Group Inc. Appoints Claudio Torres as Chairman of the Board
-
BP Prudhoe Bay Royalty Trust Offers Overriding Royalty in North America’s Largest Oil Field
-
Abvance Therapeutics Secures Strategic Seed Financing & Leadership Expansion at ADA Scientific Sessions
